News & Blog

Latest from the Blog

  1. March 18, 2016

    Moving The Field Toward More Patient-Focused Drug Development

    23982169463_252ae8b95f_o

    Together with our partners in the Jumpstarting Brain Tumor Drug Development Coalition – Accelerate Brain Cancer Cure (ABC2), Musella Foundation for Brain Tumor Research and Education, and the Society for Neuro-Oncology – NBTS has been advocating for the brain tumor research field to take patients’ quality of life into great account during clinical trials. As […]

    Read more | 
  2. March 14, 2016

    So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development

    STK_AnalyzingBrainScan

    Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […]

    Read more | 
  3. March 9, 2016

    CONNECT with Community Events

    18207869048_f9b5af7c50_k

    Donors, Volunteers and Friends, It is a pleasure to have this new and exciting connection method of communicating to you each and every month! I wanted to take this first opportunity to say THANK YOU for all that you do for NBTS to support our research and advocacy. Although we do have talented staff sprinkled across […]

    Read more | 
Share